Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angels for Action is a non-profit foundation dedicated to finding a cure for X-linked Adrenoleukodystrophy (X-ALD), a rare and devastating neurodegenerative disorder. Founded by families affected by the disease, the organization focuses on funding high-impact medical research, including gene therapy and hematopoietic stem cell transplantation. A core component of their mission is the "Stop ALD" initiative, which advocates for universal newborn screening to ensure early diagnosis and intervention. The foundation collaborates with leading academic institutions and biotechnology companies to accelerate the translation of laboratory discoveries into clinical treatments. By providing both financial support for research and resources for patient families, Angels for Action plays a critical role in the ALD therapeutic landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angels for Action.